Name: Latest research reports of Divi's Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer

5914.5000 -217.00 (-3.54%)

NSE Aug 08, 2025 15:31 PM

28.14% Gain from 52W Low

Volume: 541.4K

Divi's Laboratories Ltd.

09 Nov 2022, 12:00AM

5914.50

-3.54%

Divi's Labs (HOLD): Disappointing quarter

Hold: Divi's Laboratories Ltd.

Target

BOB Capital Markets Ltd.

Q2 revenue fell 7% YoY to Rs 18.5bn, weighed down by a decline in custom synthesis business

Divi's Laboratories Ltd. has lost -15.31% in the last 1 Month